Neelakantan Ramineni Inc San Diego, CA - 92115

Neelakantan Ramineni Inc is categorized under Internal Medicine Doctors in San Diego, CA and active since 1985.

Neelakantan Ramineni Inc was established in 1985, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Patricia Cortez, Office Manager at the company’s single location by writing to 4537 College Avenue, San Diego, California CA 92115 or by phoning (619) 265-0504. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Neelakantan Ramineni Inc
Contact Person: Patricia Cortez, Office Manager
Address: 4537 College Avenue, San Diego, California 92115
Phone Number: (619) 265-0504
Annual Revenue (USD): $100.000 to $499.999
Founded: 1985
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Neelakantan Ramineni Inc was started in 1985 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Patricia Cortez, Office Manager for inquiries that concern Neelakantan Ramineni Inc by calling the company number (619) 265-0504, as your correspondence is most welcome. Additionally, the physical location of the single location of Neelakantan Ramineni Inc can be found at the coordinates 32.75934,-117.06624 as well as the street address 4537 College Avenue in San Diego, California 92115.

For its online presence, you may visit Neelakantan Ramineni Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.